Anti-tumor effects of combined doxorubicin and siRNA for pulmonary delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumor effects of combined doxorubicin and siRNA for pulmonary delivery

Published:2017-04 Issue:4 Volume:28 Page:807-812
ISSN:1001-8417
Container-title:Chinese Chemical Letters
language:en
Short-container-title:Chinese Chemical Letters

Author:

Xu Cai-Na,Tian Hua-Yu,Wang Yan-Bing,Du Yang,Chen Jie,Lin Lin,Guo Zhao-Pei,Chen Xue-Si

Funder

National Natural Science Foundation of China

Jilin Province Science and Technology Development Program

National Program for Support of Top-notch Young Professionals

Publisher

Elsevier BV

Subject

General Chemistry

Reference23 articles.

1. The state state of lung cancer research: a global analysis;Aggarwal;J. Thorac. Oncol.,2016

2. Scientific advances in lung cancer 2015;Tsao;J. Thorac. Oncol.,2016

3. Long noncoding RNAs in lung cancer: what we know in 2015;Xu;Clin. Transl. Oncol.,2016

4. An overview of the effective combination therapies for the treatment of breast cancer;Núñez;Biomaterials,2016

5. Co-delivery of drugs and plasmid DNA for cancer therapy;Teo;Adv. Drug Deliv. Rev.,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cationic covalent organic framework nanocarriers integrating both efficient gene silencing and real-time gene detection;Chinese Chemical Letters;2024-04

2. A Scalable Freeze-Dissolving Approach to Prepare Ultrafine Crystals for Inhalation: Mechanism and Validation;Crystal Growth & Design;2024-03-21

3. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review;AAPS PharmSciTech;2024-02-29

4. Recent progresses of exosome–liposome fusions in drug delivery;Chinese Chemical Letters;2024-02

5. Endogenous Enzyme-Activatable Spherical Nucleic Acids for Spatiotemporally Controlled Signal Amplification Molecular Imaging and Combinational Tumor Therapy;Analytical Chemistry;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3